drugset / Trial / NCT00185133

Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension

NCT00185133

Phase 3 Completed 1900 enrolled Daiichi Sankyo
RandomizedParallel-groupDouble-blindTreatment

Summary

This study assesses the efficacy and safety of co-administration of olmesartan medoxomil plus amlodipine in mild to severe hypertensive patients older than 18 years of age

Timeline

Start
2005-05
Primary completion
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified
Subject Olmesartan medoxomil Unknown

Indications